Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-391-3 | CAS number: 140-01-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral: 1 acute oral study using DTPA acid; 4 acute oral studies using pentasodium DTPA; 2 acute oral studies using pentapotassium DTPA.
Dermal: 1 acute dermal study using pentapotassium DTPA
Inhalation: 1 acute inhalation study using pentasodium DTPA; 1 sub-acute inhalation study using Disodium EDTA (read across)
Key value for chemical safety assessment
Additional information
The acute oral toxicity of DTPA is low, with LD50 values for the acid and the salt in excess of 2000 mg/kg bw/day. Limited details are available from the studies regarding the potential cause of mortality, however some of the studies did indicate some apparent effects on the kidneys and liver. There is very little difference in the toxicity associated with the pentapotassium, pentasodium salts of DTPA and the acid when one considers the amount of DTPA provided per dose of each substance.
The acute dermal toxicity of DTPA acid and the sodium and potassium salts is very low (LD50 >2000 mg/kg bw). This is consistent with the fact that the dermal penetration of DTPA is very low (<0.1%), as such, dermal dosing of this material will not result in a high enough systemic dose to produce overt toxicity or mortality.
Acute inhalation summary:
DTPA acid, potassium and sodium salts are not volatile. Therefore the potential for acute inhalation exposure to vapors of these substances is remote. In a study performed using Pentasodium DTPA, rats exposed for 8 hours to the vapour generated at room temperature did not suffer any adverse effects. (There was however no measurement of the actual amount of DTPA in the air in that study). Acute inhalation exposure to the solid form of these materials is self limiting due to the particle sizes of the powders (90% >60 micrometers diameter) which will significantly limit the amount inhaled and delivered to the respiratory tract. However, an inhalation study performed using the powder form of disodium EDTA (refer to repeated dose inhalation studies) did result in 6 deaths out of 20 male rats following a single 6 hour exposure to 1000 mg/m3 disodium EDTA. The test material used in this study was processed to achieve a MMAD of approximately 2 micrometers. Therefore this would constitute a worst case exposure situation where 100% of the test material was respirable. In the remaining 14 animals there were no adverse effects reported at necropsy following a 14 day observation period. Therefore these effects were fully reversible within the observation period.
The toxicity observed in the study is considered to be due to the chelating agent complexing calcium within cells of the alveoli and terminal bronchioles following its impaction there. This leads to the break down of epithelial membranes and leads to the edema and congestion observed which ultimately led to deaths. As this toxicity is related to chelation of metals such as calcium locally in the lung it is considered it would be relevant to DTPA acid, Pentasodium DTPA and pentapotassium DTPA since each of these has a similar affinity for calcium compared to EDTA.
Justification for classification or non-classification
Oral and Dermal Acute toxicity: No classification is required.
Inhalation:
The toxicity observed in the inhalation study conducted using the read across substance, disodium EDTA, indicates that classification for acute inhalation toxicity may be warranted. In the study the particle size of the test material was approximately 2 micrometers (MMAD). In commercial DTPA acid and Pentasodium DTPA powder the average particle size is >100 micrometers, with typically less then 4% having a size less than 10 micrometers in diameter. As such the concentration of commercial powder in the air that would be required to produce the lethality seen in the inhalation study would be more than 20 times higher (>20000 mg/m3). Thus the commercially produced powders would not pose an acute inhalation hazard. However it is possible that users could process the powder further or produce concentrated liquid aerosols with a smaller, respirable particle size. In these situations DTPA could pose an acute inhalation hazard, if the concentration dosed to the lungs were sufficient.
Considering the data available, exposure for 6 hours to a concentration of 1000 mg/m3 disodium EDTA produced 6 deaths in 20 animals. DTPA would be considered to have equivalent potency due to similar chelating constants for calcium. The cut off for classification of a dust/aerosol as harmful is an LC50 between 1000 and 5000 mg/m3 for an inhalation exposure for 4 hours. In the study the exposure period was for 6 hours, however it is likely that an exposure to a concentration between 1000 and 5000 mg/m3 for 4 hours could have resulted result in at least 50% of the animals dying. Therefore it is considered appropriate to classify this substance as Acute Inhalation Category 4 according to the CLP regulation; R20, Harmful via inhalation, according to the DSD.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.